Ignite Creation Date:
2025-12-24 @ 3:22 PM
Ignite Modification Date:
2025-12-25 @ 1:41 PM
Study NCT ID:
NCT04278092
Status:
COMPLETED
Last Update Posted:
2025-05-08
First Post:
2020-02-18
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Paclitaxel Plus Cetuximab After First-line Checkpoint Inhibitor Failure
Sponsor:
Medical University of Vienna
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-02-10
Start Date Type:
ACTUAL
Primary Completion Date:
2024-10-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-10-31
Completion Date Type:
ACTUAL
First Submit Date:
2020-02-18
First Submit QC Date:
None
Study First Post Date:
2020-02-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-05-05
Last Update Post Date:
2025-05-08
Last Update Post Date Type:
ACTUAL